| RS2147283135 |
TNNI3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 7, Hypertrophic cardiomyopathy 7 |
| RS2147283171 |
TNNI3
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1FF, Dilated cardiomyopathy 1FF |
| RS2147283343 |
CNKSR2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked |
| RS2147283349 |
LDLR
|
Health Risk |
Likely pathogenic |
— |
| RS2147283407 |
CNKSR2
|
Health Risk |
Pathogenic |
— |
| RS2147284796 |
MORC2
|
Health Risk |
Pathogenic |
Developmental delay, impaired growth |
| RS2147285302 |
TNNI3
|
Health Risk |
Pathogenic |
Cardiomyopathy, familial restrictive |
| RS2147285332 |
TNNI3
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2147285611 |
RPGR
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, RPGR-related retinopathy |
| RS2147285764 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS2147286730 |
LAMP2
|
Health Risk |
Pathogenic |
Danon disease, Danon disease |
| RS2147286839 |
LAMP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Danon disease, Cardiovascular phenotype |
| RS2147286859 |
LDLR
|
Health Risk |
Likely pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2147287002 |
LDLR
|
Health Risk |
Likely pathogenic |
Familial hypercholesterolemia, Hypercholesterolemia |
| RS2147287035 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2147287052 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2147287083 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2147287215 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS2147287353 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2147287460 |
MID1
|
Health Risk |
Pathogenic |
X-linked Opitz G/BBB syndrome, X-linked Opitz G/BBB syndrome |
| RS2147287476 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS2147287553 |
PI4KA
|
Health Risk |
Pathogenic |
Polymicrogyria, perisylvian |
| RS2147287565 |
LAMP2
|
Health Risk |
Pathogenic |
Danon disease, Danon disease |
| RS2147287579 |
LAMP2
|
Health Risk |
Pathogenic |
— |
| RS2147287624 |
LAMP2
|
Health Risk |
Pathogenic |
Primary dilated cardiomyopathy, Danon disease |
| RS2147287637 |
LAMP2
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2147287645 |
LAMP2
|
Health Risk |
Pathogenic |
Danon disease, Danon disease |
| RS2147287657 |
LAMP2
|
Health Risk |
Pathogenic |
Cardiomyopathy, Cardiomyopathy |
| RS2147287662 |
LAMP2
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, Cardiomyopathy |
| RS2147290510 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 3, Retinitis pigmentosa 3 |
| RS2147290553 |
RPGR
|
Health Risk |
Likely pathogenic |
RPGR-related retinopathy, RPGR-related retinopathy |
| RS2147291671 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS2147291936 |
RPGR
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 3, Retinal dystrophy |
| RS2147294800 |
LAMP2
|
Health Risk |
Pathogenic |
Danon disease, Danon disease |
| RS2147294814 |
LAMP2
|
Health Risk |
Pathogenic |
Danon disease, Danon disease |
| RS2147294820 |
LAMP2
|
Health Risk |
Likely pathogenic |
Primary dilated cardiomyopathy, Primary dilated cardiomyopathy |
| RS2147294924 |
LAMP2
|
Health Risk |
Likely pathogenic |
Danon disease, Danon disease |
| RS2147297973 |
DNAAF3
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary ciliary dyskinesia 2, Primary ciliary dyskinesia |
| RS2147299107 |
DNAAF3
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2147299274 |
MID1
|
Health Risk |
Pathogenic |
— |
| RS2147299486 |
MID1
|
Health Risk |
Likely pathogenic |
X-linked Opitz G/BBB syndrome, X-linked Opitz G/BBB syndrome |
| RS2147305526 |
GATA1
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, GATA binding protein 1 related thrombocytopenia with dyserythropoiesis |
| RS2147305615 |
GATA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Diamond-Blackfan anemia, GATA binding protein 1 related thrombocytopenia with dyserythropoiesis |
| RS2147305680 |
PCNT
|
Health Risk |
Pathogenic |
— |
| RS2147305695 |
GATA1
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, GATA binding protein 1 related thrombocytopenia with dyserythropoiesis |
| RS2147305721 |
GATA1
|
Health Risk |
Pathogenic |
GATA binding protein 1 related thrombocytopenia with dyserythropoiesis, Diamond-Blackfan anemia |
| RS2147305736 |
GATA1
|
Health Risk |
Pathogenic |
GATA binding protein 1 related thrombocytopenia with dyserythropoiesis, Diamond-Blackfan anemia |
| RS2147306077 |
GATA1
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, GATA binding protein 1 related thrombocytopenia with dyserythropoiesis |
| RS2147307937 |
ARHGEF9
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2147307979 |
ARHGEF9
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 8 |
| RS2147310210 |
CIC;PAFAH1B3
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 45 |
| RS2147311724 |
DNAAF3
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2147313207 |
CIC
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 45 |
| RS2147313671 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS2147314874 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS2147317628 |
AR
|
Health Risk |
Likely pathogenic |
— |
| RS2147317782 |
AR
|
Health Risk |
Pathogenic |
— |
| RS2147318231 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS2147318633 |
ARX
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS2147318663 |
AR
|
Health Risk |
Pathogenic |
Kennedy disease, Androgen resistance syndrome |
| RS2147318790 |
ARX
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS2147318823 |
ARX
|
Health Risk |
Pathogenic |
Corpus callosum agenesis-abnormal genitalia syndrome, Corpus callosum agenesis-abnormal genitalia syndrome |
| RS2147320305 |
ARX
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked |
| RS2147320329 |
ARX
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, X-linked |
| RS2147320332 |
ARX
|
Health Risk |
Pathogenic |
X-linked spasticity-intellectual disability-epilepsy syndrome, X-linked spasticity-intellectual disability-epilepsy syndrome |
| RS2147320407 |
ARX
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 1 |
| RS2147320576 |
ARX
|
Health Risk |
Likely pathogenic |
X-linked lissencephaly with abnormal genitalia, X-linked lissencephaly with abnormal genitalia |
| RS2147320638 |
ARX
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS2147320644 |
ARX
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS2147320674 |
CIC
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 45 |
| RS2147321167 |
AR
|
Health Risk |
Likely pathogenic |
Male infertility with azoospermia or oligozoospermia due to single gene mutation, Male infertility with azoospermia or oligozoospermia due to single gene mutation |
| RS2147321505 |
CUL4B
|
Health Risk |
Pathogenic |
— |
| RS2147321510 |
CUL4B
|
Health Risk |
Likely pathogenic |
X-linked intellectual disability Cabezas type, X-linked intellectual disability Cabezas type |
| RS2147321608 |
AR
|
Health Risk |
Likely pathogenic |
Ovarian cancer, Ovarian cancer |
| RS2147322042 |
ARX
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked |
| RS2147322083 |
AR
|
Health Risk |
Likely pathogenic |
— |
| RS2147322621 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS2147322941 |
AR
|
Health Risk |
Pathogenic |
AR-related disorder, Androgen resistance syndrome |
| RS2147323184 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS2147323593 |
ARX
|
Health Risk |
Pathogenic/Likely pathogenic |
Arachnoid cyst, Corpus callosum |
| RS2147323625 |
ARX
|
Health Risk |
Pathogenic |
Corpus callosum agenesis-abnormal genitalia syndrome, Corpus callosum agenesis-abnormal genitalia syndrome |
| RS2147323888 |
FCHO1
|
Health Risk |
Pathogenic |
— |
| RS2147323943 |
ARX
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS2147324110 |
ARX
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked |
| RS2147324181 |
ARX
|
Health Risk |
Pathogenic |
X-linked lissencephaly with abnormal genitalia, X-linked lissencephaly with abnormal genitalia |
| RS2147324296 |
ARX
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS2147324381 |
ARX
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, X-linked |
| RS2147324418 |
ARX
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 1 |
| RS2147324428 |
CELSR1
|
Health Risk |
Pathogenic |
Lymphatic malformation 9, Lymphatic malformation 9 |
| RS2147324956 |
OTC
|
Health Risk |
Pathogenic/Likely pathogenic |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS2147325489 |
ARX
|
Health Risk |
Pathogenic |
Partington syndrome, Partington syndrome |
| RS2147325502 |
ARX
|
Health Risk |
Pathogenic |
Corpus callosum agenesis-abnormal genitalia syndrome, Corpus callosum agenesis-abnormal genitalia syndrome |
| RS2147330536 |
OTC
|
Health Risk |
Likely pathogenic |
Ornithine carbamoyltransferase deficiency, Thyroid cancer |
| RS2147336391 |
ODAD1
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2147336769 |
CASK
|
Health Risk |
Pathogenic |
Intellectual disability, CASK-related |
| RS2147337039 |
ODAD1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2147340483 |
DDX3X
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 102 |
| RS2147340518 |
DDX3X
|
Health Risk |
Pathogenic |
— |
| RS2147340616 |
DDX3X
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 102 |
| RS2147341270 |
OTC
|
Health Risk |
Conflicting classifications of pathogenicity |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |